Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Oxidative Stress in Gulf War Illness
NCT04987775Phase 1Recruiting
- Sponsor
- Nova Southeastern University
- Start
- Nov 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Gulf War syndrome (GWS) comparing N-Acetyl Cysteine with Placebo (2 arms). Primary endpoint: Serum glutathione (GSH) concentration at 8 weeks. Started Nov 2023; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
Gulf War syndrome (GWS)
Beyond the preview
Go deeper on NCT04987775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04987775.